Home LiteratureArticle Details
PMID: 7104174 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Digitoxin accumulation.

British journal of clinical pharmacology ·Vol. 14 ·No. 2 ·1982-08-00 ·Pages 225-9

Ochs HR, Pabst J, Greenblatt DJ, Hartlapp J

Abstract

1 Nine healthy volunteers received single 1 mg intravenous doses of digitoxin, following which serum digitoxin concentrations were measured at multiple points in time over the next 14 days. 2 Mean kinetic variables for digitoxin were: volume of distribution, 0.76 l/kg; elimination half-life, 8 days; total clearance, 0.049 ml min-1 kg-1. 3 After a drug-free interval of at least 4 months, subjects took 0.07 mg of oral digitoxin daily for 28 consecutive days. Serum digitoxin concentrations were measured during the period of dosage and in the 21 day post-dosage washout. 4 Digitoxin accumulation was slow, proceeding with a mean half-life (7.9 days) that was nearly identical to the single-dose half-life. However, the two were not significantly correlated. 5 Mean observed steady-state serum concentrations (15.4 ng/ml) also were nearly identical to those predicted from the single-dose study (15.3 ng/ml), but again the two were not significantly correlated. 6 Steady state is very slowly attained after initiation of maintenance therapy with digitoxin. The kinetic data suggest that a loading dose on the average should be 12 times the maintenance dose.

MeSH Terms
Adult Digitoxin/administration & dosage,metabolism Female Humans Kinetics Male
Chemicals
Digitoxin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ochs H R
Pabst J
Greenblatt D J
Hartlapp J
References (7)
7 references, click to expand
  1. Radioimmunoassay for serum digitoxin concentration: methodology and clinical experience.
    J Pharmacol Exp Ther. 1970 Nov;175(2):352-60 PMID: 5481705
  2. Drug therapy. Clinical Pharmacokinetics (first of two parts).
    N Engl J Med. 1975 Oct 2;293(14):702-5 PMID: 1160938
  3. Clinical pharmacokinetics of digitoxin.
    Clin Pharmacokinet. 1977 Jul-Aug;2(4):292-311 PMID: 902449
  4. Predicting steady state serum concentrations of drugs.
    Annu Rev Pharmacol Toxicol. 1979;19:347-56 PMID: 378103
  5. Noninteraction of digitoxin and quinidine.
    N Engl J Med. 1980 Sep 18;303(12):672-4 PMID: 7402253
  6. Single- and multiple-dose kinetics of intravenous digoxin.
    Clin Pharmacol Ther. 1980 Sep;28(3):340-5 PMID: 7408393
  7. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
    Eur J Clin Pharmacol. 1981 Jan;19(1):45-51 PMID: 7461023
Article Info
Journal
British journal of clinical pharmacology
Abbr.
Br J Clin Pharmacol
ISSN
0306-5251
Published
1982-08-00
Pages
225-9
Language
English
Region
England
NLM ID
7503323
PMCID
PMC1427752
Subset
IM
Grants
NIMH NIH HHS · MH-34223 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com